These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25766432)

  • 1. The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.
    Ueda M; Uchimura K; Narita Y; Miyasato Y; Mizumoto T; Morinaga J; Hayata M; Kakizoe Y; Adachi M; Miyoshi T; Shiraishi N; Kadowaki D; Sakai Y; Mukoyama M; Kitamura K
    Nephron; 2015; 129(3):223-32. PubMed ID: 25766432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
    Narita Y; Ueda M; Uchimura K; Kakizoe Y; Miyasato Y; Mizumoto T; Morinaga J; Hayata M; Nakagawa T; Adachi M; Miyoshi T; Sakai Y; Kadowaki D; Hirata S; Mukoyama M; Kitamura K
    J Pharmacol Sci; 2016 Feb; 130(2):110-6. PubMed ID: 26887332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a serine protease inhibitor on the progression of chronic renal failure.
    Hayata M; Kakizoe Y; Uchimura K; Morinaga J; Yamazoe R; Mizumoto T; Onoue T; Ueda M; Shiraishi N; Adachi M; Miyoshi T; Sakai Y; Tomita K; Kitamura K
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1126-35. PubMed ID: 22832926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifibrotic effect of a serine protease inhibitor in the kidney.
    Morinaga J; Kakizoe Y; Miyoshi T; Onoue T; Ueda M; Mizumoto T; Yamazoe R; Uchimura K; Hayata M; Shiraishi N; Adachi M; Sakai Y; Tomita K; Kitamura K
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F173-81. PubMed ID: 23698112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
    Maekawa A; Kakizoe Y; Miyoshi T; Wakida N; Ko T; Shiraishi N; Adachi M; Tomita K; Kitamura K
    J Hypertens; 2009 Jan; 27(1):181-9. PubMed ID: 19145783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
    Mikami K; Goto T; Miura K; Ohshima S; Yoneyama K; Lin JG; Watanabe D; Segawa D; Kataoka E; Shibuya T; Watanabe S
    J Gastroenterol; 2005 Mar; 40(3):260-5. PubMed ID: 15830285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Ameliorates Kidney Function and Oxidative Stress in Experimental Chronic Kidney Disease.
    Ali BH; Al-Salam S; Al Suleimani Y; Al Kalbani J; Al Bahlani S; Ashique M; Manoj P; Al Dhahli B; Al Abri N; Naser HT; Yasin J; Nemmar A; Al Za'abi M; Hartmann C; Schupp N
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):65-73. PubMed ID: 28561324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serine protease inhibitor camostat mesilate prevents podocyte apoptosis and attenuates podocyte injury in metabolic syndrome model rats.
    Mizumoto T; Kakizoe Y; Nakagawa T; Iwata Y; Miyasato Y; Uchimura K; Adachi M; Deng Q; Hayata M; Morinaga J; Miyoshi T; Izumi Y; Kuwabara T; Sakai Y; Tomita K; Kitamura K; Mukoyama M
    J Pharmacol Sci; 2021 Aug; 146(4):192-199. PubMed ID: 34116732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease.
    Diwan V; Gobe G; Brown L
    Pharmacol Res; 2014 Jan; 79():104-10. PubMed ID: 24291534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
    Inoue S; Sugitani A; Yamamoto H; Kitada H; Motoyama K; Okabe Y; Ohta M; Yoshida J; Nishiyama K; Tanaka M
    Surgery; 2005 Feb; 137(2):216-24. PubMed ID: 15674204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
    Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
    Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low-protein diet supplemented with ketoacids plays a more protective role against oxidative stress of rat kidney tissue with 5/6 nephrectomy than a low-protein diet alone.
    Gao X; Wu J; Dong Z; Hua C; Hu H; Mei C
    Br J Nutr; 2010 Feb; 103(4):608-16. PubMed ID: 19878616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity.
    Kakizoe Y; Miyasato Y; Onoue T; Nakagawa T; Hayata M; Uchimura K; Morinaga J; Mizumoto T; Adachi M; Miyoshi T; Sakai Y; Tomita K; Mukoyama M; Kitamura K
    J Pharmacol Sci; 2016 Oct; 132(2):145-153. PubMed ID: 27773435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy.
    Onbe T; Makino H; Kumagai I; Haramoto T; Murakami K; Ota Z
    J Diabet Complications; 1991; 5(2-3):167-8. PubMed ID: 1770033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.
    Naito Y; Fujii A; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Morisawa D; Eguchi A; Hirotani S; Masuyama T
    Hypertens Res; 2015 Jul; 38(7):463-70. PubMed ID: 25693854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor.
    Senda S; Fujiyama Y; Bamba T; Hosoda S
    Intern Med; 1993 Apr; 32(4):350-4. PubMed ID: 8358131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
    Jia D; Taguchi M; Otsuki M
    Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats.
    Jing W; Nunes ACF; Farzaneh T; Khazaeli M; Lau WL; Vaziri ND
    J Pharmacol Exp Ther; 2018 Oct; 367(1):129-137. PubMed ID: 30093458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of renal sympathetic nerve overactivation in the progression of chronic kidney disease in rats.
    Kobuchi S; Tanaka R; Funai A; Suzuki R; Yazawa M; Tsutsui H; Ohkita M; Ayajiki K; Matsumura Y
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):9-15. PubMed ID: 24084211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.